Novel Phenolic Inhibitors of Small/Intermediate-Conductance Ca²⁺-Activated K⁺ Channels, KCa3.1 and KCa2.3

• Aida Oliván-Viguera,

  Affiliations Aragon Institute of Health Sciences I+CS, Zaragoza, Spain, Department of Cardiovascular and Renal Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark

  ⨯
• Marta Sofía Valero,

  Affiliation GIMACES, Faculty of Health Sciences, Universidad San Jorge, Villanueva de Gállego, Spain

  ⨯
• María Divina Murillo,

  Affiliation Department of Pharmacology and Physiology, Facultad de Veterinaria, Universidad de Zaragoza, Zaragoza, Spain

  ⨯
• Heike Wulff,

  Affiliation Department of Pharmacology, University of California Davis, Davis, California, United States of America

  ⨯
• Ángel-Luis García-Otín,

  Affiliations Aragon Institute of Health Sciences I+CS, Zaragoza, Spain, GIPASC, Laboratorio de Investigación Molecular, Hospital Universitario Miguel Servet, Zaragoza, Spain

  ⨯
• José-Miguel Arbonés-Mainar,

  Affiliations Aragon Institute of Health Sciences I+CS, Zaragoza, Spain, Adipocyte and Fat Biology Laboratory, Hospital Universitario Miguel Servet, Zaragoza, Spain

  ⨯
• Ralf Köhler

  * E-mail: rkohler.iacs@aragon.es

  Affiliations Aragon Institute of Health Sciences I+CS, Zaragoza, Spain, Department of Cardiovascular and Renal Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark, Fundación Agencia Aragonesa para la Investigación y Desarrollo (ARAID), Zaragoza, Spain

  ⨯